Summary. Plasma immunoreactive glucagon, C-peptide and substrates (glucose, lactate, and alanine) were measured in 21 pancreatectomized patients and 28 patients with chronic calcifying pancreatitis during arginine infusion. Results were compared with those obtained in control and in insulin-dependent diabetic subjects, and in pancreatectomized subjects receiving a combined infusion of glucagon and arginine or somatostatin and arginine. Plasma immunoreactive glucagon in the pancreatectomized patients was 230 _+ 26 pg/ml (control subjects 100 ___ 13 pg/ml, p < 0.001), but was unchanged following arginine or somatostatin. Following ethanol extraction of plasma it became undetectable. Similar results were obtained in patients with chronic pancreatitis. In contrast to the insulin-dependent diabetic subjects, no changes in blood glucose, lactate, and alanine concentrations were found during arginine infusion in the pancreatectomized or pancreatitis patients. Addition of glucagon restored the metabolic response to arginine in the pancreatectomized patients. Our results confirm previous smaller studies that in pancreatectomized patients, A cell function is absent or insignificant.
It is well established that in several animal species glucagon-like material can be released from extra-pancreatic sites [1] [2] [3] [4] [5] [6] . In the dog, the stomach produces substantial amounts of glucagon which is immunologically [7] and biologically [8, 9] indistinguishable from pancreatic glucagon. In human subjects, however, the situation is less clear, although several authors have considered that pancreatectomized subjects represent a model of diabetes without glucagon [10] [11] [12] . The final solution of this problem is fraught with difficulties: 1) totally pancreatectomized subjects are not often available for metabolic and hormonal studies; 2) in many cases, the stomach and duodenum, as potential sources of extra-pancreatic glucagon [13] , have been removed with the pancreas; and 3) cross-reacting substances of gastrointestinal origin [14, 15] and the presence in plasma of an interfering globulin [16] or 'big plasma glucagon' [17] may render the interpretation of radioimmunoassays difficult. In order to clarify this problem, 21 pancreatectomized subjects were submitted to arginine infusion and plasma glucagon immunoreactivity (IRG) was measured with a C-terminal antibody before and after ethanol extraction. The metabolic responses to arginine were assessed by measurement of blood glucose, lactate and alanine levels. The patients were compared with normal subjects, patients with chronic calcifying pancreatitis, and insulin-dependent diabetics free of detectable chronic pancreatitis.
Subjects and Methods

Subjects
The main clinical characteristics of the subjects are shown in Table 1 . Of the 21 pancreatectomized subjects, two had undergone operation because of exocrine pancreatic carcinoma, and one because of an intractable juxtaduodenal insulinoma. All the others had presented either with acute necrotizing pancreatitis or with a chronic pancreatitis. Total pancreatectomy was performed by a standardised technique, totally removing the pancreatic gland, the duodenum, the spleen and the antropyloric two-thirds of the stomach [18] . In the second group the diagnosis of chronic pancreatitis was based on the presence of chronic diarrhoea and steatorrhoea, abdominal pain, and radiological evidence of pancreatic calcification. Most of these patients were chronic abusers of ethanol. Six had been submitted to a partial resection (four-fifths) of the pan- 
Glucagon 4-Arginine infusion:
Crystalline glucagon (Novo, Copenhagen) was dissolved in 0.154 mol/1 saline solution immediately before use. A bolus IV dose of 8 ug was given, followed by 0.57 ug/min for 30 rain, mixed with arginine. These doses have been shown to produce glucagon concentrations in plasma comparable to those measured in uncontrolled diabetic patients [19] . Four pancreatectomized patients received this infusion.
Other tests: Arginine (25 g) was administered orally, after an overnight fast, to six pancreatectomized patients; glucose (50 g) to four pancreatectomized patients. Interruption of insulin therapy for 36 h was performed in one pancreatectomized patient, after which a IV arginine infusion was performed.
Assays
Glucagon immunoreactivity: IRG was determined in plasma samples using the 30 K antiserum (Dr. R. H. Unger, Dallas, Texas) [20] the standard curves being constructed in 0.2 tool/1 glycine buffer containing 5 g/1 serum albumin and 10 g/1 sheep serum. The lowest amount of glucagon standard which gave a significant variation of the bound/free ratio from the zero standard was 7 pg/ml, corresponding in whole plasma to a detection limit of 21 pg/ml. Interassay variation was less than 5%. Aliquots of plasma were also submitted to ethanol fractionation [21] : 0.2 ml plasma were mixed with 0.36 ml ethanol 96% (v/v) at 5 o C, then centrifuged at 4 ~ C; the supernatant was lyophilized and resuspended in 0.2 ml glycine buffer (0.2 tool/l, pH 8.6) containing 2.5 g/1 bovine serum albumin. Recovery was 75%-85%: the values determined after the extraction procedure were corrected accordingly.
Other methods: C-peptide was determined [23] using an antiserum directed against human synthetic C-peptide (BYK. Mallinckrod, Dietzenbach, FGR); the lowest amount of C-peptide standard giv-ing a significant variation of the bound/free ratio from zero standard was 0.2 ng/ml (whole plasma). The inter-assay variation was less than 4%. Glucose was measured by a glucose-oxidase method [24] adapted for the Beckman analyzer (glucose analyzer Mark 3G A2, Beckman Instruments, Fullerton, CA). Alanine and lactate were determined by enzymatic methods [25, 26] .
Calculations
Results are presented as mean • SEM. Statistical analysis was performed employing Student's t test for unpaired samples [27] .
Results
Basal Values(Table 2)
After an overnight fast, blood glucose was significantly higher in all diabetic groups than in control subjects. Blood lactate and alanine were significantly higher in both the pancreatectomized patients and the subjects with chronic pancreatitis than in the two other groups. This difference was particularly marked for lactate in the pancreatectomized group.
Plasma C-peptide values were lower in all diabetic groups than in control subjects. In all pancreatectomized patients they were undetectable. Plasma IRG levels in unextracted plasma samples were significantly higher in all diabetic groups than in the control subjects. However, following extraction by ethanol, IRG levels were 28 _+ 5 pg/ml in the pancreatectomized patients, almost at the limit of sensitivity and significantly lower than in control subjects (p < 0.001). In the patients with chronic pancreatitis, extracted plasma IRG levels were not significantly different from controls: 45 + 5 versus 48 _+ 10 pg/ml. Liver function tests were within normal limits in all subjects. 
Arginine Infusion Test
In control subjects (Fig. 1) arginine infusion induced the expected significant rise in C-peptide and IRG concentrations. Blood lactate decreased significantly, while no significant changes occurred in glucose and alanine.
In the insulin-dependent patients arginine induced a rise in glucagon concentration, more pronounced than in controls, while the C-peptide level remained lower than normal and did not increase significantly. Blood glucose rose, while lactate and alanine concentrations declined, these changes being significant and related in time to the rise of plasma IRG.
In the pancreatectomized patients (Fig. 2 ) plasma IRG (unextracted samples) did not change significandy during the arginine infusion. C-peptide levels remained undetectable. No significant changes in blood glucose, lactate and alanine concentrations were found. The subjects with chronic pancreatitis displayed a pattern similar to that of pancreatectomized patients. However, a slight but significant rise of IRG level occurred at 30 and 90 min (p < 0.05); Cpeptide values, although measurable, did not rise. Blood glucose, lactate and alanine concentrations did not change significantly.
The pattern of plasma IRG was markedly changed by ethanol extraction of samples (Fig. 3) . In control subjects, IRG values in extracted samples rose acutely during the stimulation period and were not different from the values obtained before extraction over this period. In contrast, extractable IRG in the pancreatectomized patients remained below the and patients with a chronic pancreatitis (n = 28). Same presentation as in Fig. 1 
Somatostatin 4-Arginine, and Glucagon 4-Arginine Infusions
As shown in Figure 4 , addition of somatostatin to the arginine infusion did not modify the pattern observed in the pancreatectomized patients. No change was found in plasma IRG, blood glucose, lactate, alanine an d plasma C-peptide concentrations. In control subjects, the same combined infusion induced the expected suppression of IRG and C-peptide levels followed by a rebound at the end of infusion. In contrast, when exogenous glucagon was added to the arginine infusion in pancreatectomized subjects, a significant increase in blood glucose occurred, accompanied by significant decreases in blood lactate and alanine concentrations.
Other Tests
Interruption of insulin therapy:
In one pancreatectomized patient, insulin therapy was interrupted for 36 h, and this patient was submitted to a complete fast for 24 h. At end of this period, IRG concentration in plasma (unextracted samples) was 318 pg/ml (mean of two samples; NS versus overnight fasting state). Arginine infusion test at that time, when blood glucose was 23 mmol/1, did not induce any rise in IRG.
Ingestion ofarginine (Table 3) 3 . Effect of arginine infusion on glucagon (IRG) concentrations measured in plasma samples before (Q) and after (A) extraction with ethanol in 31 control subjects, 21 pancreatectomized patients and 28 patients with chronic pancreatitis. Same presentation as in Fig. 1 limk of sensitivity of the assay and did not rise during the stimulatory period. In the patients with pancreatitis, values were higher than in the pancreatectomized patients but did not change significantly (Fig. 3) .
Oral glucose tolerance test (Table 3) : Ingestion of 50 g glucose induced, in a group of four pancreatectomized subjects, a slight but significant increase in IRG concentration (p < 0.05), as measured by the 30 K antiserum in plasma samples not submitted to extraction by ethanol.
Discussion
Our results show that in pancreatectomized patients plasma IRG was detectable before ethanol extraction but disappeared or remained close to the limit of assay sensitivity following this extraction. Furthermore, plasma IRG in unextracted samples did not rise during arginine infusion in these patients and remained barely detectable in extracted samples. Somatostatin infusion did not influence this pattern in eight patients. The modifications of blood glucose, lactate, alanine which follow arginine infusion in insulin-dependent diabetics were not observed in the pancreatectomized group, suggesting the absence of release of biologically active glucagon. In the patients with chronic pancreatitis, whose stomachs were still present, the hormonal and metabolic pattern was very similar to that observed in pancreatectomized (and partially gastrectomized) patients. Infusion of exogenous glucagon in pancreatectomized subjects reproduced the changes in glucose, lactate and alanine which are observed when endogenous glucagon is released under influence of IV arginine, in the absence of any and an IV infusion ofglucagon (right panel, n = 4). Same presentation as in Fig. 1 concomitant insulin release. These points are consistent with the concept of an exclusive pancreatic source of glucagon in man. At least 17 papers have been published on the debated point of extra-pancreatic glucagon in man, based on approximately 52 pancreatectomized subjects and 65 patients with chronic pancreatitis and/or partial resection of the pancreas (Table 4 ). The majority of published results suggest that extra-pancreatic sources of immunoreactive and biologically active glucagon are insignificant in man: plasma glucagon in the basal state was either undetectable, or significantly lower than in normal and in diabetic subjects [9, 11, 12, 15, [29] [30] [31] [32] [33] [34] [35] [36] . Furthermore a deficient or absent plasma IRG response occurred following IV infusion of amino acids [9, 11, 15, 28, 30, 33, 34, 36] , interruption of insulin therapy [9] or insulin-induced hypoglycaemia [29, 30] . This latter test is however less meaningful than the others, since diabetic A cells are not as sensitive to hypoglycaemia as normal A cells [37] . The lack of suppression of plasma IRG by somatostatin [34] is another line of evidence for the non-hormonal nature of 'big plasma glucagon'. In most of these papers a C-terminal antiserum was used, usually the 30 K antiserum, and various procedures were employed to avoid non-specific plasma interference. These include extraction procedures [9, 11, 12, 15, 31, 33, 38] and/or construction of standard curves with 'deglucagonized' plasma [9, 11] . It must be emphasized, however, that proving the absence of a factor is much more difficult and problematic than confirmation o fits existence. The particular metabolic features observed in these patients may be more significant. These include high blood alanine levels in the basal state [38] , the delayed rise of blood glucose and ketone bodies following cessation of insulin therapy [9, 12] and the absence of a rise in blood glucose during arginine infusion [6, 11, 15, 34] . The present study is consistent with these previous results and documents further the presence of high lactate levels in the basal state and the persistence of blood alan• during arginine infusion. These metabolic features may repre- sent a pattern diametrically opposite to that described in the glucagonoma syndrome [39] . Six other studies, however, have documented the presence of IRG or glucagon-like immunoreactivity in plasma from pancreatectomized patients (a total of 13 subjects) and from some groups of patients with chronic pancreatitis [31, 40, 44] ; the 30 K antiserum was used in most of these reports and plasma samples were submitted to various extraction procedures in three studies [31, 42, 43] . However plasma IRG was not increased by arginine [42, 431, adrenaline [42] or cessation of insulin therapy [43] ; it was paradoxically increased by oral glucose or meals [43] . It was also not wholly or partially suppressed by somatostatin [43, 44] . All these features suggest that plasma IRG in these patients is very different from that measured in other situations.
The significance of'big plasma glucagon' remains obscure. Some extra pancreatic sources of IRG, particularly the salivary glands, have been documented in man [45, 46] ; most attempts at conversion of 'big plasma glucagon' to 3,500 dalton IRG using proteolytic digestion seem to have yielded fragments of 2,000 daltons rather than 'true' glucagon [33] . Some peptides reacting with the N-terminal antiglucagon antisera are detectable in plasma from pancreatectomized patients and their concentrations may rise after ingestion of glucose [14] but their biological properties remain difficult to interpret. Thus the properties of A cells appear very different in man and also in the macacus Rhesus [47] from that in dogs [2, 3, 5, 6] and several other animal species [4 (review) ].
In pancreatectomized patients, the absence of significant glucagon release may contribute to the well-known tendency of these patients to be prone to insulin-induced hypoglycaemia [47] .
